Yan Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Metastatic Renal Cell Carcinoma

Coronary Artery Bypass

Neoadjuvant Chemotherapy

Top Venues

Cancer biology & medicine

Cancer medicine

World journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li, Yan Li
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer biology & medicine 21 (7) (2024)
Yan-Dong Su, Ru Ma, Yu-Bin Fu, He-Liang Wu, Xin-Li Liang, Yi-Tong Liu, Yang Yu, Zhi-Ran Yang, Yan Li
Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma. Journal of surgical oncology (2024)
Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li, Yan Li
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer biology & medicine (2024)
Ru Ma, Yan-Dong Su, Feng-Cai Yan, Yu-Lin Lin, Ying Gao, Yan Li
A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis. Cancer medicine 13 (6) (2024)
Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li, Yan Li
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer biology & medicine 21 (7) (2024)
Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li, Yan Li
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer biology & medicine 21 (7) (2024)
Ru Ma, Yan-Dong Su, Feng-Cai Yan, Yu-Lin Lin, Ying Gao, Yan Li
A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis. Cancer medicine 13 (6) (2024)
Yu-Lin Lin, Jun-Qi Zhu, Rui-Qing Ma, Wei Meng, Zi-Yue Wang, Xin-Bao Li, Ru Ma, He-Liang Wu, Hong-Bin Xu, Ying Gao, Yan Li
Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei. Molecular cancer research : MCR (2023)
He-Liang Wu, Zhi-Ran Yang, Yan-Dong Su, Ru Ma, Xue-Mei Du, Ying Gao, Yan Li
Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases. World journal of surgical oncology 20 (1) (2022)
He-Liang Wu, Zhi-Ran Yang, Li-Jun Yan, Yan-Dong Su, Ru Ma, Yan Li
NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine. World journal of surgical oncology 20 (1) (2022)
Xin Zhao, Xin-Bao Li, Yu-Lin Lin, Ru Ma, Ying Zhang, Da-Zhao Xu, Yan Li
Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Cancer medicine (2022)
Feng-Cai Yan, Quan Zhou, Yulin Lin, Chunkai Yu, Hong Chang, Yan Li
Clinicopathological analysis of primary carcinoid tumour of the ovary arising in mature cystic teratomas. The Journal of international medical research 49 (8) (2021)
Yu-Lin Lin, Da-Zhao Xu, Xin-Bao Li, Feng-Cai Yan, Hong-Bin Xu, Zheng Peng, Yan Li
Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet journal of rare diseases 16 (1) (2021)
Jia-Mei Chen, Bo Luo, Ru Ma, Xi-Xi Luo, Yong-Shun Chen, Yan Li
Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer. Diagnostics (Basel, Switzerland) 12 (1) (2021)
Xue-Mei Du, Ya-Ping Wei, Ying Gao, Zhao Li, Jian-Mei Zhang, Hong Chang, Yan Li
Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report. Medicine 100 (12) (2021)
Feng-Cai Yan, Feng Shi, Xinbao Li, Hong Chang, Mulan Jin, Yan Li
Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin. The Journal of international medical research 49 (6) (2021)
Jue Zhang, Xin-Bao Li, Zhong-He Ji, Ru Ma, Wen-Pei Bai, Yan Li
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients. BioMed research international 2021 (2021)
Guo-Jun Yan, Zhong-He Ji, Gang Liu, Yan Li
CRS + HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: Case report of long-term survival. Medicine 99 (41) (2020)
Xin-Bao Li, Kai-Wen Peng, Zhong-He Ji, Yang Yu, Gang Liu, Yan Li
Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 25 (2020)
Yu-Lin Lin, Ru Ma, Yan Li
The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review. Journal of cancer research and clinical oncology 146 (9) (2020)
Fengcai Yan, Feng Shi, Xinbao Li, Chunkai Yu, Yulin Lin, Yan Li, Mulan Jin
Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries. Cancer management and research 12 (2020)
Yu-Lin Lin, Jue Zhang, Feng-Cai Yan, Xi Jiang, Ru Ma, Zhi-Ran Yang, Hong-Bin Xu, Zheng Peng, Qian Chen, Yan Li
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil. Cancer medicine 9 (3) (2019)
XinBao Li, ZhongHe Ji, Yan Li
Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration. Indian journal of surgical oncology 10 (Suppl 1) (2019)